...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >CYTOTOXICITY AND ANTIMICROBIAL ACTIVITY OF MONO-, DI- AND TRINUCLEAR RUTHENIUM(II) POLYPYRIDINE COMPLEXES
【24h】

CYTOTOXICITY AND ANTIMICROBIAL ACTIVITY OF MONO-, DI- AND TRINUCLEAR RUTHENIUM(II) POLYPYRIDINE COMPLEXES

机译:单,二和三核钌(II)聚吡啶复合物的细胞毒性和抑菌活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives: To evaluate the in vitro cytotoxicity, antibacterial and antifungal activity of the synthesized mono-, di- and trinuclear ruthenium(II) polypyridine complexes. Methods: A series of synthesized ruthenium(II) complexes, R1, R2 and R3, are screened for in vitro antiproliferative activity against HepG2 cancer cell line using 96-well plate method. An assay of antimicrobial activity was performed by disc diffusion method. In addition an assay of an antifungal was performed by broth micro-dilution method. Results: The cytotoxicity of complexes revealed IC 50 values of 14.52 (R3), 19.53 (R2) and 22.32 μM (R1) against HepG2 cell line in a dose dependent manner. All the complexes inhibited moderately the growth of Gram positive bacteria (G + ) such as Staphylococcus aureus (MRSA), Eubacterium lentum, and Bacillus subtillis , quite meagerly the growth of the Gram negative bacterium (G ─ ), Enterobacter aerogenes, but did not inhibit at all the growth of Erwinia amylovora (MTCC 2760) and showed a slight antifungal activity. Conclusion: From this study, we could suggest that the systematic increase in number of imidazole moiety along with expanding cloud of conjugated π-electron system of ruthenium(II) polypyridine complexes is responsible for the antiproliferative activity which increases in the order, R1 < R2 < R3 against HepG2 cancer cells. Consecutively, the complexes show good antimicrobial activity against Gram positive bacteria, but show poor or no effect against Gram negative bacteria and exhibit a little antifungal activity. Keywords: HepG2 cancer cells, Cytotoxicity, MTT assay, Antibacterial activity, Antifungal activity, Ruthenium polypyridyl complexes.
机译:目的:评估合成的单核,二核和三核钌(II)聚吡啶复合物的体外细胞毒性,抗菌和抗真菌活性。方法:使用96孔板法筛选一系列合成的钌(II)配合物R1,R2和R3的体外抗HepG2癌细胞增殖活性。通过盘扩散法进行抗微生物活性的测定。另外,通过肉汤微量稀释法进行抗真菌测定。结果:复合物的细胞毒性显示,其对HepG2细胞系的IC 50值为14.52(R3),19.53(R2)和22.32μM(R1),呈剂量依赖性。所有的复合物均适度抑制了革兰氏阳性菌(G +)的生长,如金黄色葡萄球菌(MRSA),扁豆真杆菌和枯草芽孢杆菌,而革兰氏阴性菌(G─),产气肠杆菌的生长却微不足道。完全抑制解淀粉欧文氏菌(MTCC 2760)的生长,并显示出轻微的抗真菌活性。结论:从这项研究中,我们可以认为,咪唑部分的数量的系统性增加以及钌(II)聚吡啶配合物的共轭π电子系统的扩展云层是造成抗增殖活性的依次原因,R1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号